Interview with Nicolás Rubió, Vice President, Industria Farmacéutica…
First of all, can you tell us about the history of Andromaco and what have been its major milestones and challenges over the years? This year marks the eightieth anniversary…
Address: Boulevard Manuel Avila Camacho No.88 piso 9, Col. Lomas de Chapultepec, Mexico D.F.
,Mexico
Tel: +52 (55) 9178 7540
Web: http://www.andromaco.com.mx/
Present in the Mexican market since 1931, Andromaco specializes in creams and gel production and is now exporting to the United States as well as having a strong presence in Mexico. In 2008, Andromaco inaugurated a new plant dedicated to the production of cosmetics and dermatological products, with cutting edge technology and the highest industry standards.
Manufacturing, production and commercialization of cream and gel cosmetic products.
First of all, can you tell us about the history of Andromaco and what have been its major milestones and challenges over the years? This year marks the eightieth anniversary…
Eduardo Tapia explains how big changes in the distribution landscape are transforming the industry, reveals how the life sciences sector has been positioned as a global priority for DHL, and…
Eric Alvarez, managing director of Janssen Mexico, explains why it is important to distinguish between the public and private sector when discussing the latest developments in the pharmaceutical industry, and…
Teleflex is committed to solving the challenges of a changing healthcare environment in the areas of critical care and surgical applications by providing every day new products. The managing director…
Internationalization and innovation are part of Chiesi’s history. The general manager of the recently started Mexican affiliate discusses the company’s priorities for the second largest market in Latin America and…
Cecilia Calderón shares her experience as founder and general manager of Vigpharma, her perspectives on the pharmacovigilance and technovigilance in Mexico and the main challenges that come with being the…
The director of Bacher Zoppi reveals how the Mexican pharma sector is back in the spotlight of the international investor community, explains how the distribution environment has evolved with power…
The corporate development director and business development manager of UpPharma explain why Market Expansion Services (MES) model represents a unique business opportunity for firms looking to establish themselves in the…
The councillor at the Swiss Embassy talks about how the two countries have a particularly close relationship when it comes to pharma, the challenge of introducing innovative products to the…
José Angel García Hinojosa, vice president sales and marketing of the Grupo Loeffler Russek, discusses the history of the company since its establishment until its most recent accomplishments. Always with…
Landsteiner is betting on biotech and genomics. The head of new developments and the head of genomic research share their views on the future of the company as well as…
The president and founder of Knobloch Information Group, the leading supplier of market data to the pharmaceutical industry in Mexico, provides an in-depth overlook about the most important changes that…
Innovation is a product’s added value, ensuring that the patient is ready to buy. The former director of R&D and today CEO of Carnot explains how the company is undergoing…
See our Cookie Privacy Policy Here